Open-Label Study to Evaluate the Inter-subject Variability of Single Dose Prolia Pharmacokinetics and Pharmacodynamics, Administered by Subcutaneous Injection in Healthy Postmenopausal Women
Latest Information Update: 15 Jun 2021
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Pharmacokinetics
- 15 Jun 2021 New trial record